Silo pharma to present at proactive's one2one virtual investor forum

Englewood cliffs, nj, feb. 23, 2021 (globe newswire) -- silo pharma, inc. (otcqb: silo), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, ptsd, parkinson's, and other rare neurological disorders, announced today that eric weisblum, chief executive officer will be presenting at proactive's one2one virtual investor forum on tuesday, february 23, at 1 p.m. est.
SILO Ratings Summary
SILO Quant Ranking